PHILADELPHIA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating SomaLogic, Inc. (NASDAQ: SLGC) on behalf of the company's investors. On October 4, 2023, SomaLogic announced that had entered into an agreement to combine with Standard BioTools Inc. ("Standard"). Under the terms of the proposed agreement, which is subject to approval by the company's stockholders, SomaLogic investors are expected to receive 1.11 shares of Standard common stock for each share of SomaLogic common stock owned. The transaction as structured appears to undervalue SomaLogic's shares. For example, prior to the announcement of the proposed merger, at least two stock analyst firms were maintaining price targets on SLGC shares of $7.00 per share.